Last reviewed · How we verify
Bridge therapy
Bridge therapy refers to a transitional treatment strategy that maintains disease control while switching between long-term therapies.
Bridge therapy refers to a transitional treatment strategy that maintains disease control while switching between long-term therapies. Used for Transitional therapy during treatment switches in neurological conditions.
At a glance
| Generic name | Bridge therapy |
|---|---|
| Sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
Bridge therapy is a clinical approach rather than a specific drug, typically used in neurology and other specialties to provide continuous therapeutic benefit during transitions between primary treatments. It serves as an interim intervention to prevent disease progression or symptom exacerbation when discontinuing one therapy before initiating another.
Approved indications
- Transitional therapy during treatment switches in neurological conditions
Common side effects
Key clinical trials
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System (NA)
- Comparison of ESWT and Deep Tissue Massage in Individuals With Medial Tibial Stress Syndrome (NA)
- Poland-Italy Aortic Research Bridge Real World Registry
- Effects of Core Stabilization Exercises in Female Patients With Gonarthrosis (NA)
- Dynamic Lumbar Strengthening Exercises Versus Pilates, Combined With Myofascial Release in Non Specific Chronic Low Back Pain (NA)
- The Effects of Manipulation on Pain, Quality of Life, and Functional Activity in People Who Practice Pilates. (NA)
- Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bridge therapy CI brief — competitive landscape report
- Bridge therapy updates RSS · CI watch RSS
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta portfolio CI